| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |